Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Beclomethasone Dipropionate
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase IV
Sponsor : Chiesi Group
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study Comparing the Effects of Trimbow to Fostair in COPD
Details : Beclometasone Dipropionate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 15, 2019
Lead Product(s) : Beclomethasone Dipropionate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase IV
Sponsor : Chiesi Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
